ARCHIVES

Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter

This article is from The Cancer Letter archive.

Vol. 02 No. 42 | October 15, 1976

Download PDF Visit The Full Archive

Related Articles

Levamisole/5-FU Could Save $226 Mil. If Fully Adopted, NCI Economist Says

April 20, 1990

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

February 21, 2003

FDA Publishes Parallel Track Rules, Accelerated Drug Approval Initiative

April 25, 1992

In Brief: ACCC Lobbyists Got What They Wanted In House Cancer Act Bill; VA Group Review Set May 2

April 28, 1978

This month’s 8-page Business & Regulatory Report included in this issue.

January 30, 2004

House Approves Additional Funds For NIH and FDA.

June 20, 2008